BOTOX in the Treatment of Crow's Feet Lines in China
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2016
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- Sponsors Allergan
- 13 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2015 Planned End Date changed from 1 Dec 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
- 16 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.